sluit venster

Log in

Gebruikersnaam Wachtwoord Gebruikersnaam en/of wachtwoord vergeten? Gebruikersnaam en wachtwoord aanvragen

Zoek in de HOVON website

Studies (all)


Study name Status Echelon level Stage Age Updated Included patients Active sites
HOVON-associated SADAL trial (Protocol KCP-330-009) Open Level A 2nd line >=18 05-03-2018 n/a n/a
HOVON Pomalidomide project Open n/a 3rd line >18 17-11-2015 n/a n/a
HOVON-associated Innate allo-SCT Open n/a - >18 10-03-2016 n/a n/a
HOVON-associated CC-122 NHL-001 Open n/a 2nd line >=18 21-04-2016 n/a n/a
HOVON-associated CMV pp65 specific T-cells Open n/a - 0 - 75 18-10-2012 n/a n/a
HOVON 900 DLBCL screening Open 1st line > 18 year 16-07-2018 1017 65
HOVON 152 DLBCL Open Level D 1st line ≥ 18 07-09-2018 3 1
HOVON 151 DLBCL Open Level A, Level B, Level C-HIC, Level C-SCT 1st line 18 - 75 10-10-2018 n/a 1
HOVON 148 AML Open Level A - 18 - 70 31-07-2018 1 1
HOVON 143 MM Open Level D 1st line > 18 08-10-2018 90 49
HOVON 141 CLL Open Level D 2nd line >=18 01-10-2018 178 45
HOVON 140 CLL Open Level D 1st line >=18 18-10-2018 n/a 36
HOVON 138 APL (APOLLO) Open Limited site selection 1st line 18 - 65 years 10-10-2018 n/a 4
HOVON 136 NHL Open Level B 2nd line >18 years 03-10-2018 2 7
HOVON 134 MF Open Level A - 18 - 70 y 18-10-2018 11 9
HOVON 133 MCL (TRIANGLE) Open Level D - 18 - 65 22-06-2018 n/a 23
HOVON 129 PCL Open Level A 2nd line >18 yrs 13-09-2018 n/a 17
HOVON 127 BL Open Level C-HIC 1st line 18-75 31-05-2018 38 22
HOVON 124 WM Open Limited site selection 2nd line >=18 y 08-06-2018 54 21
HOVON 119 MCL Open Level D 1st line >= 60 17-10-2018 n/a 24
HOVON 114 MM Open Limited site selection 2nd line >= 18 20-08-2018 n/a 32
HOVON 113 MSC Open Level A, Level B 2nd line Any age 03-05-2018 33 7
HOVON 110 FL Open n/a 2nd line >= 18 years 20-09-2018 82 50
HOVON 103 AML Open Level C-HIC 1st line >=66 19-04-2018 664 30
HOVON-associated MM and haplo Open n/a 3rd line < 66 yrs 23-05-2016 n/a n/a
HOVON-associated EMN17 Perseus Trial Planned Level A - 18-70 19-09-2018 n/a n/a
HOVON 156 AML Planned Level C-HIC & C-SCT - >=18 y 02-08-2018 n/a n/a
HOVON 153 NIVEAU Planned Level D 2nd line >65 19-02-2018 n/a n/a
HOVON 150 AML Planned Level C-HIC & C-SCT - >18 jaar 03-10-2018 n/a n/a
HOVON 147 SMM Planned Level C-HIC 2nd line >=18 years 03-09-2018 n/a n/a
HOVON 144 NHL Planned Level D 2nd line 18-70 en 71-85 03-05-2018 n/a n/a
HOVON 142 CML -SUSTRENIM-CML1415 Planned Level A, Level B, Level C-HIC & C-SCT 1st line ≥18 03-05-2018 n/a n/a
HOVON 137 NHL Planned Level D - >= 75 03-05-2018 n/a n/a
HOVON-associated Transplant BRaVE Closed n/a - >=18 03-05-2018 n/a n/a
HOVON-associated PLMA25 NK-cell study Closed n/a - >= 55 29-09-2015 n/a n/a
HOVON-associated Murano study Closed n/a 2nd line >= 18 31-08-2015 n/a n/a
HOVON-associated GO27878 study (Cavalli study) Closed n/a - >=18 09-02-2017 n/a n/a
HOVON-associated CARINA (Protocol 54767414LYM2001) Closed Limited site selection 3rd line >=18 07-12-2016 n/a n/a
HOVON-associated Anti-CD20 cGVHD study Closed n/a - >=18 09-12-2015 n/a n/a
HOVON-associated Acerta CL-007 Closed n/a - >65 OR >18 - 65 23-03-2018 n/a n/a
HOVON-associated Acerta CL-006 Closed n/a 2nd line >=18 23-03-2018 n/a n/a
HOVON-associated ACE WM-001 Closed n/a - >=18 24-12-2015 n/a n/a
HOVON-associated ACE LY-004 Closed n/a - >=18 24-12-2015 n/a n/a
HOVON 149 AL Amyloidosis Closed n/a - 18 - 70 03-05-2018 n/a n/a
HOVON 139 CLL (GIVE) Closed Level D 1st line >=18 08-10-2018 70 25
HOVON 135 AML / SAKK Closed Limited site selection 1st line >=66 18-06-2018 147 34
HOVON 132 AML / SAKK Closed Limited site selection 1st line 18 - 65 03-05-2018 909 52
HOVON 131 MM / IFM 2015-01 Closed n/a 1st line 18-65 03-05-2018 n/a n/a
HOVON 130 NHL Closed Level D 1st line ≥ 18 20-09-2018 83 23
HOVON 126 MM Closed Limited site selection 1st line 03-05-2018 143 40
HOVON 123 MM Closed Level D 1st line >= 75 03-05-2018 240 57
HOVON 121 CLLM1/GCLLSG Closed Level D - ≥ 18 03-05-2018 n/a 4
HOVON 120 NHL (ZEST) Closed n/a 2nd line > = 60 03-05-2018 n/a n/a
HOVON 116 AML Closed Level A 1st line 18 - 70 03-05-2018 140 7
HOVON 115 Double UCBT Closed Level A - 03-05-2018 70 6
HOVON 109 CLL Closed Limited site selection 1st line 65 years – 80 years, inclusive; 18 - 64 years, inclusive, with CIRS ≥7 03-05-2018 63 34
HOVON 108 MM Closed Level A 2nd line 18-65 03-05-2018 30 7
HOVON 107 MOBILIZATION Closed Level A - 18-60 03-05-2018 38 4
HOVON 106 DOUBLE UCBT Closed n/a - 18-65 03-05-2018 41 5
HOVON 105 PCNSL / ALLG NHL24 Closed Level C-HIC 1st line 18 - 70 03-05-2018 200 28
HOVON 104 AL AMYLOIDOSIS Closed n/a 1st line 18-70 03-05-2018 57 18
HOVON 102 AML Closed Limited site selection 1st line 18 - 65 03-05-2018 862 45
HOVON 101 CLL/OMB112517 Closed n/a 2nd line >= 18 03-05-2018 n/a 19
HOVON 100 ALL / EORTC Closed Level C-SCT 3rd line 18 - 70 03-05-2018 373 30
HOVON 98 / OMB110928 Closed n/a 2nd line >=18 03-05-2018 n/a n/a
HOVON 97 AML Closed Level C-HIC 1st line >= 60 03-05-2018 116 25
HOVON 96 GVHD Closed n/a 1st line 18 - 70 21-09-2018 494 7
HOVON 95 MM Closed Level D 1st line 18-65 03-05-2018 n/a 191
HOVON 93 AML / EBMT Closed Level B 1st line >= 60 <= 75 03-05-2018 n/a 6
HOVON 92 AML / SAKK Closed Limited site selection 1st line 18 - 65 03-05-2018 n/a n/a
HOVON 91 T-NHL (ACT-2) Closed n/a 1st line 61-80 03-05-2018 n/a n/a
HOVON 90 T-NHL (ACT-1) Closed n/a 1st line 18 - 60 years 03-05-2018 n/a n/a
HOVON 89 MDS Closed Level D 1st line >=18 19-08-2018 184 54
HOVON 88 CLL Closed n/a 2nd line 18 - 70 03-05-2018 46 18
HOVON 87 MM Closed Level D 1st line prev. untreated > 65 or <=65 when inelig. for HDT & PCST 20-06-2018 643 96
HOVON 86 MM Closed Level C-HIC & C-SCT 2nd line >=18 03-05-2018 81 25
HOVON 85 NHL Closed n/a 2nd line >=18 03-05-2018 61 27
HOVON 84 NHL Closed n/a 1st line 18 - 80 03-05-2018 585 68
HOVON 82 Sanquin Closed n/a 1st line >= 18 03-05-2018 295 8
HOVON 81 AML Closed n/a 1st line > 60 03-05-2018 n/a n/a
HOVON 80 NHL Closed n/a 2nd line 18 - 65 03-05-2018 36 12
HOVON 79 APL / PETHEMA LPA 2005 Closed Level B 1st line 18 - 75 03-05-2018 90 11
HOVON 78 CML Closed n/a 1st line 18 - 65 20-06-2018 110 30
HOVON 77 NHL Closed n/a 1st line > 60 03-05-2018 19 24
HOVON 76 MM Closed n/a 1st line 18 - 66 03-05-2018 35 8
HOVON 75 MCL Closed n/a 1st line 18 - 65 03-05-2018 132 16
HOVON 74 ALL Closed n/a 2nd line 18 - 70 03-05-2018 2 8
HOVON 73 NHL / PRIMA Closed n/a 1st line >= 18 03-05-2018 18 14
HOVON 72 AML Closed n/a 2nd line 18 - 60 03-05-2018 2 1
HOVON 71 ALL Closed n/a 1st line 40 - 70 03-05-2018 60 21
HOVON 70 ALL Closed n/a 1st line 18 - 39 03-05-2018 54 20
HOVON 69 T-NHL Closed n/a 1st line 18 - 65 03-05-2018 20 19
HOVON 68 CLL Closed n/a 1st line 18 - 75 03-05-2018 274 71
HOVON 67 AML / SAKK Closed n/a 1st line >= 60 03-05-2018 6 9
HOVON 66 AML Closed n/a 1st line 18 - 60 03-05-2018 n/a n/a
HOVON 65 MM / GMMG HD4 Closed n/a 1st line 18 - 65 03-05-2018 828 75
HOVON 64 ITP Closed n/a 1st line > 18 03-05-2018 151 35
HOVON 63 NHL Closed n/a 1st line 18 - 65 03-05-2018 40 31
HOVON 61 NHL Closed n/a 1st line >= 65 03-05-2018 n/a 7
HOVON 60 MDS / SAKK 33/99 Closed n/a 1st line > 18 19-08-2018 6 3
HOVON 59 AML / SAKK / OSHO Closed n/a 1st line 16 - 75 03-05-2018 22 5
HOVON 58 ET Closed n/a 1st line 18 - 80 03-05-2018 7 9
HOVON 57 MM Closed n/a 1st line >= 18 03-05-2018 24 10
HOVON 55 MCL Closed n/a 1st line >=65 or 60-65 (see inclusion criteria) 03-05-2018 95 30
HOVON 54 MM Closed n/a 1st line 18 - 65 20-06-2018 87 6
HOVON 53 AML / OSHO Closed n/a 1st line 50 - 75 03-05-2018 59 10
HOVON 52 AML Closed n/a 1st line 18 - 75 03-05-2018 n/a n/a
HOVON 51 CML Closed n/a 1st line 18 - 65 19-08-2018 164 16
HOVON 50 MM Closed n/a 1st line 18 - 65 03-05-2018 555 47
HOVON 49 MM Closed n/a 1st line > 65 03-05-2018 344 64
HOVON 48 NHL / NHLFIT Closed n/a 2nd line >= 18 03-05-2018 n/a n/a
HOVON 47 NHL Closed n/a 1st line > 65 03-05-2018 13 39
HOVON 46 NHL Closed n/a 1st line >= 65 03-05-2018 265 73
HOVON 45 MCL Closed n/a 1st line 18 - 65 03-05-2018 87 17
HOVON 44 NHL Closed n/a 2nd line 18 - 65 03-05-2018 232 24
HOVON 43 AML Closed n/a 1st line > 60 20-06-2018 n/a n/a
HOVON 42 AML / SAKK Closed n/a 1st line 18 - 60 03-05-2018 1002 4
HOVON 42 A AML / SAKK Closed n/a 1st line 18 - 60 03-05-2018 514 24
HOVON 41 AL Amyloidosis Closed n/a 1st line < 66 03-05-2018 70 13
HOVON 40 NHL Closed n/a 1st line 18 - 65 03-05-2018 93 21
HOVON 39 NHL / EORTC 20981 Closed n/a 2nd line > 18 03-05-2018 77 32
HOVON 38 CML Closed n/a 1st line 16 - 65 03-05-2018 102 22
HOVON 37 ALL Closed n/a 1st line 16 - 59 03-05-2018 243 12
HOVON 36 MM Closed n/a 1st line > 64 03-05-2018 69 49
HOVON 35 NHL / EORTC 20963 Closed n/a 1st line 18 - 66 03-05-2018 n/a n/a
HOVON 34 MDS / EORTC 06961 Closed n/a 1st line 10 - 60 19-08-2018 n/a n/a
HOVON 32 MDS / ELDERLY AML Closed n/a 1st line 15 - 75 19-08-2018 n/a n/a
HOVON 30 AML Closed n/a 1st line > 18 03-05-2018 80 19
HOVON 29 AML / SAKK 30/95 Closed n/a 1st line 15 - 60 03-05-2018 n/a n/a
HOVON 27 NHL 94 Closed n/a 1st line 15 - 65 03-05-2018 n/a n/a
HOVON 26 NHL Closed n/a 1st line 15 - 65 03-05-2018 486 72
HOVON 25 NHL / OG 95-004 Closed n/a 1st line > 65 03-05-2018 n/a n/a
HOVON 24 MM / OG 96-020 Closed n/a 1st line < 66 03-05-2018 n/a n/a
HOVON 20 CML Closed n/a 1st line > 18 03-05-2018 n/a n/a
HOVON 18 ALL Closed n/a 1st line 16 - 60 03-05-2018 193 19
HOVON-associated MEDI4736-NHL-001 Closed n/a 2nd line >= 18 18-01-2018 n/a n/a
HOVON-associated MK-3475-087 Closed n/a 2nd line >=18 02-05-2016 n/a n/a
HOVON-associated GO29365 Closed Limited site selection 1st line >=18 14-10-2016 n/a n/a
HOVON 146 ALL On hold Level A, Level B 1st line 18 - 70 29-08-2018 2 n/a
HOVON 117 ALL On hold n/a 1st line >=55 03-05-2018 n/a 1
HOVON 112 MSC On hold Level A 1st line Any age 03-05-2018 39 2